These included donor age, female sex, cerebrovascular accident (CVA)/stroke as the cause of death, underlying diseases, history of cocaine or methamphetamine use, high-inotrope requirement during donor management, cardiac troponin I >1.0 mg/L, left ventricular dysfunction (defined as left-ventricular ejection fraction < 50%), left-ventricular regional wall motion abnormalities, and left-ventricular hypertrophy. This evidence concerns the gene TNNI3 and left ventricular hypertrophy.